{
    "clinical_study": {
        "@rank": "132850", 
        "arm_group": [
            {
                "arm_group_label": "Radio-Frequency Ablation", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in this arm will receive treatment with radio-frequency ablation."
            }, 
            {
                "arm_group_label": "Cryothearpy", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in this arm will receive treatment with cryotherapy."
            }
        ], 
        "brief_summary": {
            "textblock": "The two treatment modalities under investigation are clinically equivalent (non-inferior) to\n      each other for the endoscopic treatment of Barrett's esophagus with HGD and/or early\n      esophageal adenocarcinoma."
        }, 
        "brief_title": "Comparison of Radiofrequency Ablation and Cryotherapy for the Treatment of Barrett's Esophagus With High-Grade Dysplasia and/or Early Adenocarcinoma", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Barrett's Esophagus", 
        "condition_browse": {
            "mesh_term": [
                "Adenocarcinoma", 
                "Barrett Esophagus"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  suitable candidates for endoscopic treatment of Barrett's esophagus (BE) with\n             high-grade dysplasia (HGD) and/or early adenocarcinoma of the esophagus\n\n        Exclusion Criteria:\n\n          -  contraindications to endoscopic treatment (e.g., bleeding diathesis, pregnancy,\n             severe medical comorbidities, advanced liver disease)\n\n          -  refusal to participate in the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01961778", 
            "org_study_id": "2013P001776"
        }, 
        "intervention": [
            {
                "arm_group_label": "Radio-Frequency Ablation", 
                "intervention_name": "Radio-Frequency Ablation", 
                "intervention_type": "Device", 
                "other_name": "Barrx"
            }, 
            {
                "arm_group_label": "Cryothearpy", 
                "intervention_name": "Cryotherapy", 
                "intervention_type": "Device", 
                "other_name": "Trufreeze, CSA Medical"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 20, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02114"
                }, 
                "name": "Massachusetts General Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective Randomized Trial Comparing Radiofrequency Ablation (Barrx\u2122) and Cryotherapy (TruFreeze\u2122) for the Treatment of Barrett's Esophagus With High-Grade Dysplasia and/or Early Adenocarcinoma", 
        "overall_contact": {
            "email": "nnishioka@partners.org", 
            "last_name": "Norman S Nishioka, MD", 
            "phone": "6177264422"
        }, 
        "overall_official": {
            "affiliation": "Massachusetts General Hospital", 
            "last_name": "Norman S Nishioka, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary endpoint of this study is the percentage of Barrett's esophagus ablated during the initial treatment session.", 
            "measure": "Percentage of Barrett's esophagus ablated during the initial treatment session.", 
            "safety_issue": "No", 
            "time_frame": "2-3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01961778"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Massachusetts General Hospital", 
            "investigator_full_name": "Norman Nishioka, MD", 
            "investigator_title": "Physician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The degree of patient discomfort (pain, amount of narcotics used) will be assessed during a telephone call to the patient 24-48 hours following the procedure.", 
            "measure": "Patient discomfort", 
            "safety_issue": "No", 
            "time_frame": "2-3 days"
        }, 
        "source": "Massachusetts General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Massachusetts General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}